Antiplatelet therapy for migraine patients due to vertebral artery hypoplasia based on digital subtraction angiography (DSA) examination

Key Points

• Antiplatelet therapy shows promise in reducing migraine frequency in patients with vertebral artery hypoplasia.
• Key evidence indicates a significant reduction in migraine episodes after initiating antiplatelet therapy, enhancing patient quality of life.
• Assessment using digital subtraction angiography for evaluating vertebral artery hypoplasia and determining suitable interventions was utilized.
• Highlighting the need for further investigation into the relationship between vascular anomalies and migraine management.